x
|
|
QUARTERLY
REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE
ACT OF
1934
|
o
|
|
TRANSITION
REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE
ACT
|
Argan,
Inc.
|
(Exact
Name of Registrant as Specified in Its
Charter)
|
Delaware
|
13-1947195
|
|
(State
or Other Jurisdiction of
Incorporation
or
Organization)
|
(I.R.S.
Employer
Identification
No.)
|
One
Church Street, Suite 401, Rockville MD
20850
|
(Address
of Principal Executive Offices) (Zip
Code)
|
(301)
315-0027
|
(Registrant’s
Telephone Number, Including Area
Code)
|
________________________________________________
|
(Former
Name, Former Address and Former Fiscal Year,
if
Changed since Last Report)
|
Large
accelerated filer o
|
Accelerated
filer o
|
Non-accelerated
filer þ
|
|
|
|
|
Page
No.
|
|
|
|
|
|
PART
I.
|
|
FINANCIAL
INFORMATION
|
|
|
|
|
|
|
|
Item
1.
|
|
Financial
Statements (unaudited)
|
|
|
|
|
|
|
|
|
|
Condensed
Consolidated Balance Sheets - October 31, 2007 and January 31,
2007
|
|
3
|
|
|
|
|
|
|
|
Condensed
Consolidated Statements of Operations for the Three and Nine Months
Ended
October 31, 2007 and 2006
|
|
4
|
|
|
|
|
|
|
|
Condensed
Consolidated Statements of Cash Flows for the Nine Months Ended October
31, 2007 and 2006
|
|
5
|
|
|
|
|
|
|
|
Notes
to Condensed Consolidated Financial Statements
|
|
6
|
|
|
|
|
|
Item
2.
|
|
Management’s
Discussion and Analysis of Financial Condition and Results of
Operation
|
|
14
|
|
|
|
|
|
Item
3.
|
|
Quantitative
and Qualitative Disclosures about Market Risk
|
|
26
|
|
|
|
|
|
Item
4.
|
|
Controls
and Procedures
|
|
26
|
|
|
|
|
|
PART
II.
|
|
OTHER
INFORMATION
|
|
27
|
|
|
|
|
|
Item
1.
|
|
Legal
Proceedings
|
|
27
|
|
|
|
|
|
Item
1a.
|
|
Risk
Factors
|
|
27
|
|
|
|
|
|
Item
2.
|
|
Unregistered
Sales of Equity Securities and Use of Proceeds
|
|
27
|
|
|
|
|
|
Item
3.
|
|
Defaults
Upon Senior Securities
|
|
27
|
|
|
|
|
|
Item
4.
|
|
Submission
of Matters to a Vote of Security Holders
|
|
27
|
|
|
|
|
|
Item
5.
|
|
Other
Information
|
|
28
|
|
|
|
|
|
Item
6.
|
|
Exhibits
|
|
28
|
|
|
|
|
|
SIGNATURES
|
|
|
|
29
|
|
October
31,
|
January
31,
|
|||||
2007
|
2007
|
||||||
ASSETS
|
|||||||
CURRENT
ASSETS
|
|
|
|||||
Cash
and cash equivalents
|
$
|
75,268,000
|
$
|
25,393,000
|
|||
Accounts
receivable, net of allowance for doubtful accounts of
$80,000
|
|||||||
at
10/31/2007 and $137,000 at 1/31/2007
|
23,974,000
|
23,030,000
|
|||||
Investments
available for sale
|
5,000,000
|
2,283,000
|
|||||
Escrowed
cash
|
14,406,000
|
15,031,000
|
|||||
Estimated
earnings in excess of billings
|
630,000
|
12,003,000
|
|||||
Current
deferred tax asset
|
539,000
|
-
|
|||||
Inventories,
net of reserves of $400,000 at 10/31/2007 and $104,000 at
01/31/2007
|
1,711,000
|
2,387,000
|
|||||
Prepaid
expenses and other current assets
|
2,194,000
|
798,000
|
|||||
TOTAL
CURRENT ASSETS
|
123,722,000
|
80,925,000
|
|||||
Property
and equipment, net of accumulated depreciation of
|
|||||||
$3,037,000
at 10/31/2007 and $2,379,000 at 1/31/2007
|
2,807,000
|
3,250,000
|
|||||
Other
assets
|
197,000
|
313,000
|
|||||
Deferred
tax asset
|
385,000
|
-
|
|||||
Goodwill
|
20,155,000
|
23,981,000
|
|||||
Other
intangible assets, net
|
6,531,000
|
12,661,000
|
|||||
TOTAL
ASSETS
|
$
|
153,797,000
|
$
|
121,130,000
|
|||
|
|||||||
CURRENT
LIABILITIES
|
|||||||
Accounts
payable
|
$
|
27,966,000
|
$
|
44,255,000
|
|||
Accrued
expenses
|
9,734,000
|
5,873,000
|
|||||
Estimated
loss on uncompleted contracts
|
68,000
|
-
|
|||||
Billings
in excess of cost and earnings
|
66,479,000
|
15,705,000
|
|||||
Current
portion of long-term debt
|
2,668,000
|
2,586,000
|
|||||
TOTAL
CURRENT LIABILITIES
|
106,915,000
|
68,419,000
|
|||||
Deferred
income tax liability
|
-
|
1,471,000
|
|||||
Other
liabilities
|
46,000
|
14,000
|
|||||
Long-term
debt
|
4,693,000
|
6,715,000
|
|||||
TOTAL
LIABILITIES
|
111,654,000
|
76,619,000
|
|||||
STOCKHOLDERS'
EQUITY
|
|||||||
Preferred
stock, par value $0.10 per share; 500,000 shares
authorized;
|
|||||||
no
shares issued and outstanding
|
-
|
-
|
|||||
Common
stock, par value $0.15 per share;
|
|||||||
30,000,000
shares authorized; 11,107,245 and 11,097,245 shares issued and
|
|||||||
11,104,012
and 11,094,012 shares outstanding at 10/31/2007 and 1/31/2007,
respectively
|
1,665,000
|
1,664,000
|
|||||
Warrants
outstanding
|
849,000
|
849,000
|
|||||
Additional
paid-in capital
|
57,492,000
|
57,190,000
|
|||||
Accumulated
other comprehensive loss
|
(39,000
|
)
|
(8,000
|
)
|
|||
Accumulated
deficit
|
(17,791,000
|
)
|
(15,151,000
|
)
|
|||
Treasury
stock at cost; 3,233 shares at 10/31/2007 and 1/31/2007
|
(33,000
|
)
|
(33,000
|
)
|
|||
TOTAL
STOCKHOLDERS' EQUITY
|
42,143,000
|
44,511,000
|
|||||
TOTAL
LIABILITIES AND STOCKHOLDERS' EQUITY
|
$
|
153,797,000
|
$
|
121,130,000
|
|
Three
months ended
October
31,
|
Nine
months ended
October
31,
|
|||||||||||
|
2007
|
2006
|
2007
|
2006
|
|||||||||
Net
sales
|
|
|
|
|
|||||||||
Power
industry services
|
$
|
42,017,000
|
$
|
-
|
$
|
130,970,000
|
$
|
-
|
|||||
Nutraceutical
products
|
4,617,000
|
5,248,000
|
14,602,000
|
16,288,000
|
|||||||||
Telecom
infrastructure services
|
2,629,000
|
4,361,000
|
7,260,000
|
10,843,000
|
|||||||||
Net
Sales
|
49,263,000
|
9,609,000
|
152,832,000
|
27,131,000
|
|||||||||
Cost
of sales
|
|||||||||||||
Power
industry services
|
35,548,000
|
-
|
119,383,000
|
-
|
|||||||||
Nutraceutical
products
|
4,193,000
|
4,235,000
|
12,481,000
|
12,561,000
|
|||||||||
Telecom
infrastructure services
|
2,076,000
|
3,506,000
|
5,776,000
|
8,507,000
|
|||||||||
Gross
profit
|
7,446,000
|
1,868,000
|
15,192,000
|
6,063,000
|
|||||||||
|
|||||||||||||
Selling,
general and administrative expenses
|
4,381,000
|
2,214,000
|
13,715,000
|
6,134,000
|
|||||||||
Impairment
of goodwill and other intangible assets
|
4,666,000
|
-
|
4,666,000
|
-
|
|||||||||
Loss
from operations
|
(1,601,000
|
)
|
(346,000
|
)
|
(3,189,000
|
)
|
(71,000
|
)
|
|||||
|
|||||||||||||
Interest
expense and amortization of
|
|||||||||||||
subordinated
debt issuance costs
|
(171,000
|
)
|
(87,000
|
)
|
(550,000
|
)
|
(564,000
|
)
|
|||||
Interest
income
|
1,074,000
|
2,000
|
2,352,000
|
5,000
|
|||||||||
Loss
from operations before
|
|||||||||||||
income
taxes
|
(698,000
|
)
|
(431,000
|
)
|
(1,387,000
|
)
|
(630,000
|
)
|
|||||
Income
tax (expense) benefit
|
(1,259,000
|
)
|
176,000
|
(1,253,000
|
)
|
202,000
|
|||||||
Net
loss
|
$
|
(1,957,000
|
)
|
$
|
(255,000
|
)
|
$
|
(2,640,000
|
)
|
$
|
(428,000
|
)
|
|
|
|||||||||||||
Earnings
per share:
|
|||||||||||||
Basic
and diluted loss per share
|
$
|
(0.18
|
)
|
$
|
(0.06
|
)
|
$
|
(0.24
|
)
|
$
|
(0.10
|
)
|
|
Weighted
average number of shares outstanding:
|
|||||||||||||
Basic
and diluted
|
11,096,000
|
4,574,000
|
11,095,000
|
4,312,000
|
|
Nine
Months Ended
October
31,
|
||||||
2007
|
2006
|
||||||
CASH
FLOWS FROM OPERATING ACTIVITIES:
|
|||||||
Net
loss
|
$
|
(2,640,000
|
)
|
$
|
(428,000
|
)
|
|
Adjustments
to reconcile net loss to net cash provided by operating
activities:
|
|||||||
Depreciation
and other amortization
|
968,000
|
1,054,000
|
|||||
Amortization
of purchased intangibles
|
5,290,000
|
991,000
|
|||||
Impairment
of goodwill and other intangible assets
|
4,666,000
|
-
|
|||||
Deferred
income taxes
|
(2,424,000
|
)
|
(491,000
|
)
|
|||
Non-cash
stock option compensation expense
|
282,000
|
185,000
|
|||||
Provision
for inventory obsolescence
|
296,000
|
(33,000
|
)
|
||||
Provision
for losses on accounts receivable
|
50,000
|
97,000
|
|||||
Loss
on disposal of assets
|
69,000
|
1,000
|
|||||
Changes
in operating assets and liabilities:
|
|||||||
Escrowed
cash
|
625,000
|
-
|
|||||
Accounts
receivable, net
|
(994,000
|
)
|
(1,472,000
|
)
|
|||
Estimated
earnings in excess of billings
|
11,373,000
|
(30,000
|
)
|
||||
Inventories,
net
|
380,000
|
1,241,000
|
|||||
Prepaid
expenses and other current assets
|
(1,396,000
|
)
|
(343,000
|
)
|
|||
Accounts
payable and accrued expenses
|
(12,428,000
|
)
|
687,000
|
||||
Billings
in excess of cost and earnings
|
50,774,000
|
3,000
|
|||||
Other
|
86,000
|
(108,000
|
)
|
||||
Net
cash provided by operating activities
|
54,977,000
|
1,354,000
|
|||||
CASH
FLOWS FROM INVESTING ACTIVITIES:
|
|||||||
Purchases
of investments
|
(19,997,000
|
)
|
-
|
||||
Proceeds
from sale of investments
|
17,271,000
|
-
|
|||||
Purchases
of property and equipment
|
(507,000
|
)
|
(778,000
|
)
|
|||
Proceeds
from sale of property and equipment
|
44,000
|
|
15,000
|
||||
Net
cash used in investing activities
|
(3,189,000
|
)
|
(763,000
|
)
|
|||
CASH
FLOWS FROM FINANCING ACTIVITIES:
|
|||||||
Net
proceeds from the exercise of stock options
|
27,000
|
-
|
|||||
Net
proceeds from the private offering of common stock
|
-
|
1,862,000
|
|||||
Principal
payments on long-term debt
|
(1,940,000
|
)
|
(478,000
|
)
|
|||
Proceeds
from long-term debt
|
-
|
1,500,000
|
|||||
Proceeds
from line of credit
|
-
|
4,575,000
|
|||||
Payments
on line of credit
|
-
|
(4,530,000
|
)
|
||||
Principal
payments on subordinated note due to a related party
|
-
|
(3,292,000
|
)
|
||||
Net
cash used in financing activities
|
(1,913,000
|
)
|
(363,000
|
)
|
|||
NET
INCREASE IN CASH AND CASH EQUIVALENTS
|
49,875,000
|
228,000
|
|||||
CASH
AND CASH EQUIVALENTS AT BEGINNING OF PERIOD
|
25,393,000
|
5,000
|
|||||
CASH
AND CASH EQUIVALENTS AT END OF PERIOD
|
$
|
75,268,000
|
$
|
233,000
|
|||
SUPPLEMENTAL
CASH FLOW INFORMATION:
|
|||||||
Cash
paid for interest and income taxes as follows:
|
|||||||
Interest
|
$
|
898,000
|
$
|
315,000
|
|||
Income
taxes
|
$
|
3,117,000
|
$
|
14,000
|
|||
Non-cash
investing and financing activities are as follows:
|
|||||||
Net
increase in fair value of interest rate swaps
|
$
|
36,000
|
$
|
7,000
|
|
October
31,
2007
|
January
31,
2007
|
|||||
Raw
materials
|
$
|
1,822,000
|
$
|
2,264,000
|
|||
Work-in
process
|
109,000
|
100,000
|
|||||
Finished
goods
|
180,000
|
127,000
|
|||||
Less:
Reserves
|
(400,000
|
)
|
(104,000
|
)
|
|||
Inventories,
net
|
$
|
1,711,000
|
$
|
2,387,000
|
|
Estimated
Useful
Life
|
Gross
Carrying Amount
|
Accumulated
Amortization
|
Net
Carrying
Amount
|
|||||||||
Intangible
assets being amortized:
|
|
|
|
|
|||||||||
Contractual
customer
relationships
- VLI & SMC
|
5-7
years
|
$
|
2,341,000
|
$
|
1,841,000
|
$
|
500,000
|
||||||
Customer
relationships - GPS
|
1-2
years
|
6,678,000
|
5,068,000
|
1,610,000
|
|||||||||
Proprietary
formulas - VLI
|
3
years
|
1,813,000
|
1,813,000
|
—
|
|||||||||
Non-compete
agreements-
GPS
& VLI
|
5
years
|
2,007,000
|
1,236,000
|
771,000
|
|||||||||
Trade
name - GPS
|
15
years
|
3,643,000
|
217,000
|
3,426,000
|
|||||||||
Intangible
assets not being amortized:
|
|||||||||||||
Trade
name - SMC
|
Indefinite
|
224,000
|
—
|
224,000
|
|||||||||
Total
other intangible assets
|
$
|
16,706,000
|
$
|
10,175,000
|
$
|
6,531,000
|
|||||||
|
|||||||||||||
Goodwill
|
Indefinite
|
$
|
20,155,000
|
$
|
—
|
$
|
20,155,000
|
|
2007
|
2006
|
|||||
Computed
expected income tax benefit
|
$
|
471,000
|
$
|
214,000
|
|||
Increase
(decrease) resulting from:
|
|||||||
State
income taxes, net
|
(386,000
|
)
|
(107,000
|
)
|
|||
Permanent
differences
|
(1,338,000
|
)
|
95,000
|
||||
|
$
|
(1,253,000
|
)
|
$
|
202,000
|
|
Nine
Months Ended
October 31, |
|
|||||
|
|
2007
|
|
2006
|
|||
Dividend
yield
|
—
|
—
|
|||||
Expected
volatility
|
71
|
%
|
57
|
%
|
|||
Risk-free
interest rate
|
4.89
|
%
|
5.11
|
%
|
|||
Expected
life in years
|
5
|
5
|
Options
|
Shares
|
Weighted-
Average
Exercise
Price
|
Weighted-
Average
Remaining
Contract
Term (Years)
|
Aggregate
Intrinsic
Value
|
|||||||||
Outstanding
at January 31, 2007
|
244,000
|
$
|
4.20
|
||||||||||
Granted
|
142,000
|
$
|
7.05
|
||||||||||
Exercised
|
(10,000
|
)
|
2.65
|
||||||||||
Forfeited
or expired
|
(3,000
|
)
|
$
|
6.32
|
|||||||||
Outstanding
at October 31, 2007
|
373,000
|
$
|
5.30
|
6.5
|
$
|
1,150,000
|
|||||||
Exercisable
at October 31, 2007
|
215,000
|
$
|
4.11
|
7.4
|
$
|
397,000
|
|
Shares
|
Aggregate
Intrinsic
Value
|
|||||
Nonvested
at January 31, 2007
|
16,000
|
||||||
Granted
|
142,000
|
||||||
Vested
|
—
|
||||||
Forfeited
|
—
|
||||||
Nonvested
at October 31, 2007
|
158,000
|
$
|
753,000
|
|
Power
Industry Services
|
Nutraceutical
Products
|
Telecom
Infrastructure
Services
|
Other
|
Consolidated
|
|||||||||||
Net
sales
|
$
|
42,017,000
|
$
|
4,617,000
|
$
|
2,629,000
|
—
|
$
|
49,263,000
|
|||||||
Cost
of sales
|
35,548,000
|
4,193,000
|
2,076,000
|
—
|
41,817,000
|
|||||||||||
Gross
profit
|
6,469,000
|
424,000
|
553,000
|
—
|
7,446,000
|
|||||||||||
|
||||||||||||||||
Selling,
general and administrative expenses
|
1,892,000
|
1,047,000
|
346,000
|
1,096,000
|
4,381,000
|
|||||||||||
Impairment
of goodwill and other intangible assets
|
—
|
4,666,000
|
—
|
—
|
4,666,000
|
|||||||||||
Income
(loss) from operations
|
4,577,000
|
(5,289,000
|
)
|
207,000
|
(1,096,000
|
)
|
(1,601,000
|
)
|
||||||||
Interest
expense
|
(145,000
|
)
|
(26,000
|
)
|
—
|
—
|
(171,000
|
)
|
||||||||
Interest
income
|
1,067,000
|
—
|
—
|
7,000
|
1,074,000
|
|||||||||||
|
||||||||||||||||
Income
(loss) before income taxes
|
$
|
5,499,000
|
$
|
(5,315,000
|
)
|
$
|
207,000
|
$
|
(1,089,000
|
)
|
(698,000
|
)
|
||||
|
||||||||||||||||
Income
tax expense
|
(1,259,000
|
)
|
||||||||||||||
|
||||||||||||||||
Net
loss
|
$
|
(1,957,000
|
)
|
|||||||||||||
Depreciation
and amortization
|
$
|
45,000
|
$
|
140,000
|
$
|
135,000
|
$
|
4,000
|
$
|
324,000
|
||||||
Amortization
of intangibles
|
$
|
947,000
|
$
|
228,000
|
$
|
26,000
|
$
|
—
|
$
|
1,201,000
|
||||||
Goodwill
|
$
|
16,476,000
|
$
|
2,739,000
|
$
|
940,000
|
$
|
—
|
$
|
20,155,000
|
||||||
Total
assets
|
$
|
124,193,000
|
$
|
9,909,000
|
$
|
4,896,000
|
$
|
14,799,000
|
$
|
153,797,000
|
||||||
Fixed
asset additions
|
$
|
31,000
|
$
|
88,000
|
$
|
164,000
|
$
|
—
|
$
|
283,000
|
Power
Industry Services
|
|
Nutraceutical
Products
|
|
Telecom
Infrastructure
Services
|
|
Other
|
|
Consolidated
|
||||||||
Net
sales
|
$
|
130,970,000
|
$
|
14,602,000
|
$
|
7,260,000
|
$
|
—
|
$
|
152,832,000
|
||||||
Cost
of sales
|
119,383,000
|
12,481,000
|
5,776,000
|
—
|
137,640,000
|
|||||||||||
Gross
profit
|
11,587,000
|
2,121,000
|
1,484,000
|
—
|
15,192,000
|
|||||||||||
Selling,
general and administrative expenses
|
6,998,000
|
3,231,000
|
1,044,000
|
2,442,000
|
13,715,000
|
|||||||||||
Impairment
of goodwill and intangible assets
|
—
|
4,666,000
|
—
|
—
|
4,666,000
|
|||||||||||
Income
(loss) from operations
|
4,589,000
|
(5,776,000
|
)
|
440,000
|
(2,442,000
|
)
|
(3,189,000
|
)
|
||||||||
Interest
expense
|
(461,000
|
)
|
(88,000
|
)
|
(1,000
|
)
|
—
|
(550,000
|
)
|
|||||||
Interest
income
|
2,343,000
|
—
|
—
|
9,000
|
2,352,000
|
|||||||||||
Income
(loss) before income taxes
|
$
|
6,471,000
|
$
|
(5,864,000
|
)
|
$
|
439,000
|
$
|
(2,433,000
|
)
|
(1,387,000
|
)
|
||||
Income
tax expense
|
(1,253,000
|
)
|
||||||||||||||
Net
loss
|
$
|
(2,640,000
|
)
|
|||||||||||||
Depreciation
and amortization
|
$
|
139,000
|
$
|
434,000
|
$
|
383,000
|
$
|
12,000
|
$
|
968,000
|
||||||
Amortization
of intangibles
|
$
|
4,375,000
|
$
|
837,000
|
$
|
78,000
|
$
|
—
|
$
|
5,290,000
|
||||||
Fixed
asset additions
|
$
|
35,000
|
$
|
212,000
|
$
|
260,000
|
$
|
—
|
$
|
507,000
|
Nutraceutical
Products
|
Telecom
Infrastructure
Services
|
Other
|
Consolidated
|
||||||||||
Net
sales
|
$
|
5,248,000
|
$
|
4,361,000
|
$
|
—
|
$
|
9,609,000
|
|||||
Cost
of sales
|
4,235,000
|
3,506,000
|
—
|
7,741,000
|
|||||||||
Gross
profit
|
1,013,000
|
855,000
|
—
|
1,868,000
|
|||||||||
Selling,
general and administrative expenses
|
1,178,000
|
411,000
|
625,000
|
2,214,000
|
|||||||||
Income
(loss) from operations
|
(165,000
|
)
|
444,000
|
(625,000
|
)
|
(346,000
|
)
|
||||||
Interest
expense and amortization of subordinated debt issuance
costs
|
(79,000
|
)
|
(12,000
|
)
|
4,000
|
(87,000
|
)
|
||||||
Other
income, net
|
—
|
2,000
|
—
|
2,000
|
|||||||||
Income
(loss) before income taxes
|
$
|
(244,000
|
)
|
$
|
434,000
|
$
|
(621,000
|
)
|
(431,000
|
)
|
|||
Income
tax benefit
|
176,000
|
||||||||||||
Net
loss
|
$
|
(255,000
|
)
|
||||||||||
Depreciation
and amortization
|
$
|
146,000
|
$
|
121,000
|
$
|
12,000
|
$
|
279,000
|
|||||
Amortization
of intangibles
|
$
|
305,000
|
$
|
26,000
|
$
|
—
|
$
|
331,000
|
|||||
Goodwill
|
$
|
6,565,000
|
$
|
940,000
|
$
|
—
|
$
|
7,505,000
|
|||||
Total
assets
|
$
|
16,200,000
|
$
|
6,439,000
|
$
|
468,000
|
$
|
23,107,000
|
|||||
Fixed
asset additions
|
$
|
92,000
|
$
|
74,000
|
$
|
—
|
$
|
166,000
|
|
Nutraceutical
Products
|
Telecom
Infrastructure
Services
|
Other
|
Consolidated
|
|||||||||
Net
sales
|
$
|
16,288,000
|
$
|
10,843,000
|
$
|
—
|
$
|
27,131,000
|
|||||
Cost
of sales
|
12,561,000
|
8,507,000
|
—
|
21,068,000
|
|||||||||
Gross
profit
|
3,727,000
|
2,336,000
|
—
|
6,063,000
|
|||||||||
Selling,
general and administrative expenses
|
3,335,000
|
1,249,000
|
1,550,000
|
6,134,000
|
|||||||||
Income
(loss) from operations
|
392,000
|
1,087,000
|
(1,550,000
|
)
|
(71,000
|
)
|
|||||||
Interest
expense and amortization of subordinated debt issuance
costs
|
(287,000
|
)
|
(41,000
|
)
|
(236,000
|
)
|
(564,000
|
)
|
|||||
Other
income, net
|
—
|
5,000
|
—
|
5,000
|
|||||||||
Income
(loss) before income taxes
|
$
|
105,000
|
$
|
1,051,000
|
$
|
(1,786,000
|
)
|
(630,000
|
)
|
||||
Income
tax benefit
|
202,000
|
||||||||||||
Net
loss
|
$
|
(428,000
|
)
|
||||||||||
Depreciation
and amortization
|
$
|
419,000
|
$
|
351,000
|
$
|
284,000
|
$
|
1,054,000
|
|||||
Amortization
of intangibles
|
$
|
914,000
|
$
|
77,000
|
$
|
—
|
$
|
991,000
|
|||||
Fixed
asset additions
|
$
|
281,000
|
$
|
489,000
|
$
|
8,000
|
$
|
778,000
|
|
·
|
|
cyclical
changes in demand for our products and services;
|
|
|
|
|
|
·
|
|
cyclical
nature of the individual markets in which our customers
operate;
|
|
|
|
|
|
·
|
|
that
the dollar amount of our backlog, as stated at any given time, is
not
indicative of our future earnings;
|
|
|
|
|
|
·
|
|
delays
or difficulties related to our projects including additional costs,
reductions in revenues or the payment of liquidated damages;
|
|
|
|
|
|
·
|
|
the
effect of our percentage-of-completion accounting
policies;
|
|
|
|
|
|
·
|
|
changes
in the estimates and assumptions we use to prepare our financial
statements;
|
|
|
|
|
|
·
|
|
our
ability to obtain surety bonds or other means of credit support for
projects;
|
|
|
|
|
|
·
|
|
our
ability to obtain waivers or amendments with our lenders or sureties,
or
to collateralize letters of credit or surety bonds
upon non-compliance with covenants in our Credit Facility or surety
indemnity agreements;
|
|
|
|
|
|
·
|
|
compliance
with certain debt covenants, which as a result, may interfere with
our
ability to successfully execute our business
plan;
|
|
|
|
|
|
·
|
|
our
indebtedness, which could adversely affect our financial condition
and
impair our ability to fulfill our obligations under
our financing arrangements;
|
|
|
|
|
|
·
|
|
various
legal, regulatory and litigation risk including but not limited to,
class
action lawsuits, regulatory activities and
associated periodic reviews of the SEC and Public Company Accounting
Oversight Board;
|
|
·
|
|
the
nature of our contracts, particularly fixed-price
contracts;
|
|
|
|
|
|
·
|
|
the
failure to meet schedule or performance requirements of our
contracts;
|
·
|
|
our
dependence on subcontractors;
|
||
|
|
|
|
|
|
·
|
|
possible
cost escalation associated with our fixed-price
contracts;
|
|
|
||||
|
·
|
|
our
ability to obtain new contracts for large-scale projects and the
timing of
the performance of these contracts;
|
·
|
|
the
effect of our reputation and financial exposure due to the failure
of our
partners to perform their contractual obligations;
|
|
·
|
|
delays
and/or defaults in customer
payments;
|
·
|
|
potential
professional liability, product liability, warranty and other potential
claims, which may not be covered by
insurance;
|
|
·
|
|
the
presence of competitors with greater financial resources and the
impact of
competitive products, services and
pricing;
|
|
|
|
|
|
·
|
|
work
stoppages and other labor problems;
|
|
|
|
|
|
·
|
|
our
liquidity position;
|
|
|
|
|
|
·
|
|
a
determination to write-off a significant amount of our intangible
assets;
|
|
|
|
|
|
·
|
|
our
ability to successfully identify, integrate and complete
acquisitions;
|
|
|
|
|
|
·
|
|
our
failure to attract and retain qualified personnel;
|
|
|
|
|
|
·
|
|
our
ability to retain key members of our management;
|
|
|
|
|
|
·
|
|
our
competitors’ ability to develop or otherwise acquire equivalent or
superior technology;
|
|
|
|
|
|
·
|
|
general
economic conditions;
|
|
|
|
|
|
·
|
|
future
changes in accounting standards or interpretations;
|
|
|
|
|
|
·
|
|
inability
to maintain an effective system of internal control, which could
result in
inaccurate reporting of our financial results
or an inability to prevent fraud;
|
|
|
|
|
|
·
|
|
provisions
in our articles of incorporation and by-laws and rights agreement
could
make it more difficult to acquire us
and may reduce the market price of our common stock;
|
|
|
|
|
|
·
|
|
changes
in the U.S. economy and global markets as a result of terrorists’
actions;
|
|
|
|
|
|
·
|
|
increases
in employee-related costs and expenses including healthcare and other
employee benefits such as unemployment
insurance and workers’ compensation; and
|
|
|
|
|
|
·
|
|
our
dependency on technology in our operations and the possible impact
of
system and information technology interruptions.
|
Three
Months Ended October 31,
|
|||||||||||||
2007
|
2006
|
||||||||||||
Net
sales
|
|
|
|
|
|||||||||
Power
industry services
|
$
|
42,017,000
|
85.3
|
%
|
$
|
—
|
—
|
%
|
|||||
Nutraceutical
products
|
4,617,000
|
9.4
|
%
|
5,248,000
|
54.6
|
%
|
|||||||
Telecom
infrastructure services
|
2,629,000
|
5.3
|
%
|
4,361,000
|
45.4
|
%
|
|||||||
Net
sales
|
49,263,000
|
100.0
|
%
|
9,609,000
|
100.0
|
%
|
|||||||
Cost
of sales **
|
|||||||||||||
Power
industry services
|
35,548,000
|
84.6
|
%
|
—
|
—
|
||||||||
Nutraceutical
products
|
4,193,000
|
90.8
|
%
|
4,235,000
|
80.7
|
%
|
|||||||
Telecom
infrastructure services
|
2,076,000
|
79.0
|
%
|
3,506,000
|
80.4
|
%
|
|||||||
Cost
of sales
|
41,817,000
|
84.9
|
%
|
7,741,000
|
80.6
|
%
|
|||||||
Gross
profit
|
7,446,000
|
15.1
|
%
|
1,868,000
|
19.4
|
%
|
|||||||
|
|||||||||||||
Selling,
general and administrative expenses
|
4,381,000
|
8.9
|
%
|
2,214,000
|
23.0
|
%
|
|||||||
Impairment
of goodwill and intangible assets
|
4,666,000
|
9.5
|
%
|
—
|
—
|
||||||||
Loss
from operations
|
(1,601,000
|
)
|
(3.3
|
)%
|
(346,000
|
)
|
(3.6
|
)%
|
|||||
|
|||||||||||||
Interest
expense and amortization of
|
|||||||||||||
subordinated
debt issuance costs
|
(171,000
|
)
|
*
|
(87,000
|
)
|
(1.0
|
)%
|
||||||
Interest
income
|
1,074,000
|
2.2
|
%
|
2,000
|
*
|
||||||||
Loss
from operations before
|
|||||||||||||
income
taxes
|
(698,000
|
)
|
(1.4
|
)%
|
(431,000
|
)
|
(4.5
|
)%
|
|||||
Income
tax (expense) benefit
|
(1,259,000
|
)
|
(2.6
|
)%
|
176,000
|
1.8
|
%
|
||||||
Net
loss
|
$
|
(1,957,000
|
)
|
$
|
(4.0
|
)%
|
$
|
(255,000
|
)
|
(2.7
|
)%
|
||
|
|||||||||||||
Earnings
per share:
|
|||||||||||||
Basic
and diluted loss per share
|
$
|
(0.18
|
)
|
$
|
(0.06
|
)
|
|||||||
Weighted
average number of shares:
|
|||||||||||||
Basic
and diluted
|
11,096,000
|
4,574,000
|
Nine
Months Ended October 31,
|
|||||||||||||
2007
|
2006
|
||||||||||||
Net
sales
|
|
|
|
|
|||||||||
Power
industry services
|
$
|
130,970,000
|
85.7
|
%
|
$
|
—
|
—
|
%
|
|||||
Nutraceutical
products
|
14,602,000
|
9.6
|
%
|
16,288,000
|
60.0
|
%
|
|||||||
Telecom
infrastructure services
|
7,260,000
|
4.7
|
%
|
10,843,000
|
40.0
|
%
|
|||||||
Net
sales
|
152,832,000
|
100.0
|
%
|
27,131,000
|
100.0
|
%
|
|||||||
Cost
of sales **
|
|||||||||||||
Power
industry services
|
119,383,000
|
91.2
|
%
|
—
|
—
|
||||||||
Nutraceutical
products
|
12,481,000
|
85.5
|
%
|
12,561,000
|
77.1
|
%
|
|||||||
Telecom
infrastructure services
|
5,776,000
|
79.6
|
%
|
8,507,000
|
78.5
|
%
|
|||||||
Cost
of sales
|
137,640,000
|
90.1
|
%
|
21,068,000
|
77.7
|
%
|
|||||||
Gross
profit
|
15,192,000
|
9.9
|
%
|
6,063,000
|
22.3
|
%
|
|||||||
|
|||||||||||||
Selling,
general and administrative expenses
|
13,715,000
|
9.0
|
%
|
6,134,000
|
22.6
|
%
|
|||||||
Impairment
of goodwill and intangible assets
|
4,666,000
|
3.0
|
%
|
—
|
—
|
||||||||
Loss
from operations
|
(3,189,000
|
)
|
(2.1
|
)%
|
(71,000
|
)
|
*
|
||||||
|
|||||||||||||
Interest
expense and amortization of
|
|||||||||||||
subordinated
debt issuance costs
|
(550,000
|
)
|
*
|
(564,000
|
)
|
(2.1
|
)%
|
||||||
Interest
income
|
2,352,000
|
1.5
|
%
|
5,000
|
*
|
||||||||
Income
(loss) from operations before
|
|||||||||||||
income
taxes
|
(1,387,000
|
)
|
(0.9
|
)%
|
(630,000
|
)
|
(2.3)
|
%)
|
|||||
Income
tax (expense) benefit
|
(1,253,000
|
)
|
(0.8
|
)%
|
202,000
|
0.7
|
%
|
||||||
Net
loss
|
$
|
(2,640,000
|
)
|
(1.7
|
)%
|
$
|
(428,000
|
)
|
$
|
(1.6
|
)%
|
||
|
|||||||||||||
Earnings
per share:
|
|||||||||||||
Basic
and diluted loss per share
|
$
|
(0.24
|
)
|
$
|
(0.10
|
)
|
|||||||
Weighted
average number of shares:
|
|||||||||||||
Basic
and diluted
|
11,095,000
|
4,312,000
|
Nine
Months Ended
October
31,
|
|||||||
|
2007
|
2006
|
|||||
Computed
“expected” tax (expense) benefit
|
$
|
471,000
|
$
|
214,000
|
|||
Increase
(decrease) resulting from:
|
|||||||
State
income taxes, net
|
(386,000
|
)
|
(107,000
|
)
|
|||
Permanent
differences
|
(1,338,000
|
)
|
95,000
|
||||
|
$
|
(1,253,000
|
)
|
$
|
202,000
|
|
Three
Months Ended
October
31,
|
Nine
Months Ended
October
31,
|
|||||||||||
|
2007
|
2006
|
2007
|
2006
|
|||||||||
Net
sales
|
|
|
|
|
|||||||||
Power
industry services
|
$
|
42,017,000
|
$
|
37,158,000
|
$
|
130,970,000
|
$
|
74,785,000
|
|||||
Nutraceutical
products
|
4,617,000
|
5,248,000
|
14,602,000
|
16,288,000
|
|||||||||
Telecom
infrastructure services
|
2,629,000
|
4,361,000
|
7,260,000
|
10,843,000
|
|||||||||
Net
sales
|
49,263,000
|
46,767,000
|
152,832,000
|
101,916,000
|
|||||||||
Cost
of sales
|
|||||||||||||
Power
industry services
|
35,548,000
|
34,313,000
|
119,383,000
|
69,542,000
|
|||||||||
Nutraceutical
products
|
4,193,000
|
4,235,000
|
12,481,000
|
12,561,000
|
|||||||||
Telecom
infrastructure services
|
2,076,000
|
3,506,000
|
5,776,000
|
8,507,000
|
|||||||||
Cost
of sales
|
41,817,000
|
42,054,000
|
137,640,000
|
90,610,000
|
|||||||||
Gross
profit
|
7,446,000
|
4,713,000
|
15,192,000
|
11,306,000
|
|||||||||
Selling
and general and administrative expenses
|
4,381,000
|
4,102,000
|
13,715,000
|
9,471,000
|
|||||||||
Impairment
of goodwill and intangible assets
|
4,666,000
|
—
|
4,666,000
|
—
|
|||||||||
Income
(loss) from operations
|
$
|
(1,601,000
|
)
|
$
|
611,000
|
$
|
(3,189,000
|
)
|
$
|
1,835,000
|
|
Three
Months Ended
October
31,
|
||||||
|
2007
|
2006
|
|||||
Net
loss, as reported
|
$
|
(1,957,000
|
)
|
$
|
(255,000
|
)
|
|
Interest
expense and amortization of debt issuance costs
|
171,000
|
87,000
|
|||||
Income
tax expense (benefit)
|
1,259,000
|
(176,000
|
)
|
||||
Depreciation
and amortization
|
324,000
|
279,000
|
|||||
Amortization
of intangible assets
|
1,201,000
|
331,000
|
|||||
Stock
option compensation expense
|
182,000
|
105,000
|
|||||
Impairment
of goodwill and other intangible assets
|
4,666,000
|
-
|
|||||
EBITDA
|
$
|
5,846,000
|
$
|
371,000
|
Nine
Months Ended
October
31,
|
|||||||
|
2007
|
2006
|
|||||
Net
loss, as reported
|
$
|
(2,640,000
|
)
|
$
|
(428,000
|
)
|
|
Interest
expense and amortization of debt issuance costs
|
550,000
|
564,000
|
|||||
Income
tax expense (benefit)
|
1,253,000
|
(202,000
|
)
|
||||
Depreciation
and amortization
|
968,000
|
797,000
|
|||||
Amortization
of intangible assets
|
5,290,000
|
991,000
|
|||||
Stock
option compensation expense
|
282,000
|
185,000
|
|||||
Impairment
of goodwill and other intangible assets
|
4,666,000
|
-
|
|||||
EBITDA
|
$
|
10,369,000
|
$
|
1,907,000
|
Exhibit
No.
|
|
Title
|
Exhibit:
31.1
|
|
Certification
of Chief Executive Officer, pursuant to Rule 13a-14(c) under the
Securities Exchange Act of 1934
|
Exhibit:
31.2
|
|
Certification
of Chief Financial Officer, pursuant to Rule 13a-14(c) under the
Securities Exchange Act of 1934
|
Exhibit:
32.1
|
|
Certification
of Chief Executive Officer, pursuant to 18 U.S.C. Section
1350
|
Exhibit:
32.2
|
|
Certification
of Chief Financial Officer, pursuant to 18 U.S.C. Section
1350
|
|
|
|
|
ARGAN,
INC.
|
|
|
|
|
December
17, 2007
|
By:
|
/s/ Rainer
Bosselmann
|
|
Rainer
Bosselmann
|
|
|
Chairman
of the Board and
Chief
Executive Officer
|
|
|
|
December
17, 2007
|
By:
|
/s/ Arthur
F.
Trudel
|
|
Arthur
F. Trudel
|
|
|
Senior
Vice President, Chief Financial Officer
and
Secretary
|